Does Critical Illness Change Levofloxacin Pharmacokinetics?

Podobne zapisy

• We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
  od: Cotta, Menino Osbert, i wsp.
  Wydane: (2016)
• Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
  od: Pea, Federico, i wsp.
  Wydane: (2012)
• A Systematic Review of Studies Reporting Antibiotic Pharmacokinetic Data in the Cerebrospinal Fluid of Critically Ill Patients with Uninflamed Meninges
  od: Kumta, Nilesh, i wsp.
  Wydane: (2020)
• Pharmacokinetics of Levofloxacin and Ciprofloxacin during Continuous Renal Replacement Therapy in Critically Ill Patients
  od: Malone, Rebecca S., i wsp.
  Wydane: (2001)
• Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function
  od: Cojutti, Pier Giorgio, i wsp.
  Wydane: (2017)